FDA accepts review for ANGLE’s Parsortix system for metastatic breast cancer
System captures and harvests intact circulating tumour cells for analysis
20th October 2020
-
Service reboot
Oli Hudson, of Wilmington Healthcare, explores how pharma should align its brand strategy with the NHS reset during the COVID recovery era
-
Nuts and bolts
What the world can learn from the UK’s pharma industry
-
Sink or swim
What does pharma have left to fight for in an EU trade deal?
News
View all
Aimmune’s peanut allergy med moves toward EU approval
CHMP grants Palforzia a positive opinion for the treatment of peanut allergic patients
20th October 2020
AZ’s Tagrisso scores priority review from FDA
Agency will review drug for the treatment of early-stage EGFR-mutated lung cancer
20th October 2020
Experts partner with UK government for COVID-19 human challenge trials
NHS, academia and private sector join forces to explore and establish trials
20th October 2020
UCB acquires new campus to support UK operations
Following completion of acquisition, site will undergo refurbishment
19th October 2020
Top trending
-
EMA confirms eligibility for submission of Moderna’s COVID-19 vaccine
-
J&J’s COVID-19 vaccine trial paused on safety concerns
-
Ten new medicines backed for EU approval
-
NIHR review identifies long-term effects of COVID-19
-
Novavax begins phase III coronavirus vaccine trial in the UK
-
Astellas to acquire iota Biosciences following R&D partnership
Web Exclusives
View all
Rethinking cancer detection
Research on early cancer detection has been hamstrung by market failure. We’ve got a plan to fix it.
Breaking borders
How society’s changing relationship with health will break down the wall between pharma brands and consumers
A helping hand
How artificial intelligence can help pharma companies reach new audiences
What does creativity really mean in healthcare?
And why does it matter more than ever following COVID-19?
Magazine
View more from the latest edition
Patient Files: Ellie Heffernan
Ellie shares her experiences with the rare disorder cutaneous T-cell lymphoma (CTCL)
Embracing diversity
Why diversity matters now more than ever...and how to put it into practice
Smart People: Dr Neil Davie
We talk to Janssen’s global therapeutic area head for pulmonary hypertension, Neil Davie, about his role at the firm and the current challenges for patients with the condition
Pandemic positives
Monia Nica outlines the temporary changes to European regulatory requirements spurred by the coronavirus pandemic
Solving the health literacy equation
What does R even mean, anyway?
Smart People: Dr Harmony P. Garges
Harmony Garges talks to PharmaTimes about her role as ViiV Healthcare’s chief medical officer and head of Global Medical, and the importance of focusing on patients
Pandemic priorities
Manpreet Sidhu looks at new health technology assessment timelines and what this might mean for pharma product pipelines
Sink or swim
What does pharma have left to fight for in an EU trade deal?
Thought Leadership
View all
The concordance conundrum – the tech divide
Consultations in a virtual world
Changing gear – how to take patient-centricity to the next level
Truly achieving a patient-focused cultural shift means pharma leaders must build momentum behind the necessity of partnering with patients to capture and incorporate their valuable insights, say Dawn Lobban and Peter Impey
Partnering with patients for the long haul
O4 Research's Moneeb Saddiq and Andrea Parke consider whether the patient-centricity story is complete or still evolving
Pharma and the modern patient: creating a real connection
Eliran Malki, co-founder and CEO of Belong.Life, explores what pharma can do to engage the modern patient
Webinars
View allDesigning Pharma organisations for success
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
